Insider Trading activities of Alexion Pharmaceuticals Inc insiders. , Part 6

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alexion Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alexion Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Alexion Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ALXN. The reporting company's CIK number is 899866.
The total value of stock buying since 2005 is $394,084,487.
The total value of stock sales since 2005 is $1,002,882,574.
The total value of stock option exercises since 2005 is $145,784,408.



Table 2. Detailed insider stock purchases, sales, and option exercises of Alexion Pharmaceuticals Inc insiders (ALXN) , Part 6
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-11-03 Norby R Douglas (Director) Sale 15,000 44.00 660,000
2009-11-03 Norby R Douglas (Director) Option Ex 15,000 7.79 116,850
2009-11-02 Bell Leonard (CEO) Sale 20,400 44.22 902,088
2009-11-02 Bell Leonard (CEO) Option Ex 20,421 32.25 658,577
2009-10-27 Mathis Larry (Director) Sale 13,000 48.42 629,460
2009-10-27 Mathis Larry (Director) Option Ex 13,000 9.87 128,309
2009-10-12 Bell Leonard (CEO) Sale 18,905 44.91 849,023
2009-10-12 Bell Leonard (CEO) Option Ex 20,000 32.25 645,000
2009-10-01 Bell Leonard (CEO) Sale 20,000 43.94 878,700
2009-10-01 Bell Leonard (CEO) Option Ex 20,000 32.25 645,000
2009-09-22 Sinha Vikas (SVP & CFO) Sale 1,833 46.27 84,812
2009-09-10 Link Max (Director) Option Ex 20,000 32.25 645,000
2009-09-01 Bell Leonard (CEO) Sale 37,810 45.82 1,732,454
2009-09-01 Bell Leonard (CEO) Option Ex 40,000 32.25 1,290,000
2009-08-24 Squinto Stephen P (EVP & Head of Research) Sale 45,800 45.00 2,061,091
2009-08-24 Squinto Stephen P (EVP & Head of Research) Option Ex 45,800 16.83 770,813
2009-08-24 Norby R Douglas (Director) Sale 17,000 45.00 765,000
2009-08-24 Norby R Douglas (Director) Option Ex 17,000 41.16 699,635
2009-08-04 Squinto Stephen P (EVP & Head of Research) Sale 4,200 45.00 189,000
2009-08-04 Squinto Stephen P (EVP & Head of Research) Option Ex 4,200 32.25 135,450
2009-08-04 Norby R Douglas (Director) Sale 2,000 45.00 90,000
2009-08-04 Norby R Douglas (Director) Option Ex 2,000 42.06 84,120
2009-07-29 Mathis Larry (Director) Sale 6,000 42.66 255,959
2009-07-27 Hallal David (Sr. VP Comm Ops, Americas) Sale 8,640 43.00 371,520
2009-07-27 Parven Alvin S (Director) Sale 15,000 40.06 600,900
2009-07-27 Parven Alvin S (Director) Option Ex 15,000 7.79 116,850
2009-07-27 Dubin Thomas I H (SVP & General Counsel) Sale 58,044 42.75 2,481,381
2009-07-27 Dubin Thomas I H (SVP & General Counsel) Option Ex 51,990 10.50 545,895
2009-07-16 Hallal David (Sr. VP Comm Ops, Americas) Sale 238 38.96 9,272
2009-07-16 Sinha Vikas (SVP & CFO) Sale 397 38.96 15,467
2009-07-16 Squinto Stephen P (EVP & Head of Research) Sale 317 38.96 12,350
2009-07-16 Bell Leonard (CEO) Sale 1,251 38.96 48,738
2009-07-16 Dubin Thomas I H (SVP & General Counsel) Sale 238 38.96 9,272
2009-07-10 Sinha Vikas (SVP & CFO) Sale 318 36.93 11,743
2009-07-10 Squinto Stephen P (EVP & Head of Research) Sale 318 36.93 11,743
2009-07-10 Bell Leonard (CEO) Sale 1,173 36.93 43,318
2009-07-10 Dubin Thomas I H (SVP & General Counsel) Sale 238 36.93 8,789
2009-06-19 Hallal David (Sr. VP Comm Ops, Americas) Sale 789 38.47 30,352
2009-06-19 Norby R Douglas (Director) Sale 20,000 40.28 805,600
2009-06-19 Norby R Douglas (Director) Option Ex 20,000 32.25 645,000
2009-06-11 Hallal David (Sr. VP Comm. Ops, Americas) Sale 3,590 38.00 136,420
2009-06-04 Dubin Thomas I H (SVP & General Counsel) Sale 10,000 37.43 374,300
2009-06-01 Keiser David W (Director) Sale 50,000 36.82 1,841,150
2009-06-01 Keiser David W (Director) Option Ex 40,000 23.56 942,400
2009-05-11 Keiser David W (Director) Sale 7,800 35.01 273,078
2009-05-07 Keiser David W (Director) Sale 2,200 35.00 77,000
2009-05-01 Keiser David W (Director) Sale 40,000 33.09 1,323,400
2009-05-01 Keiser David W (Director) Option Ex 40,000 15.27 610,800
2009-04-27 Link Max (Director) Sale 40,000 33.94 1,357,600
2009-04-17 Bell Leonard (CEO) Option Ex 26,670 19.80 528,199
2009-04-01 Keiser David W (Director) Sale 58,233 36.30 2,113,916
2009-04-01 Keiser David W (Director) Option Ex 40,000 11.38 455,200
2009-03-23 Sinha Vikas (Sr. VP & CFO) Sale 1,585 37.65 59,675
2009-03-17 Bell Leonard (CEO) Option Ex 52,385 25.11 1,315,177
2009-03-16 Sinha Vikas (Sr. VP & CFO) Sale 2,357 34.25 80,727
2009-03-16 Squinto Stephen P (EVP & Head of Research) Sale 2,717 34.25 93,057
2009-03-16 Keiser David W (Director) Sale 3,281 34.25 112,374
2009-03-16 Bell Leonard (CEO) Sale 8,455 34.25 289,583
2009-03-16 Dubin Thomas I H (SVP & General Counsel) Sale 2,232 34.25 76,446
2009-03-16 Norby R Douglas (Director) Sale 32,000 35.26 1,128,160
2009-03-16 Norby R Douglas (Director) Option Ex 30,000 8.97 269,100
2009-03-13 Keiser David W (Director) Sale 10,000 35.01 350,100
2009-03-10 Squinto Stephen P (EVP & Head of Research) Sale 319 32.34 10,316
2009-03-10 Keiser David W (Director) Sale 304 32.34 9,831
2009-03-10 Parven Alvin S (Director) Sale 4,000 32.78 131,120
2009-03-10 Bell Leonard (CEO) Sale 1,174 32.34 37,967
2009-03-10 Dubin Thomas I H (SVP & General Counsel) Sale 1,031 32.34 33,342
2009-03-02 Keiser David W (Director) Sale 40,000 33.21 1,328,400
2009-03-02 Keiser David W (Director) Option Ex 40,000 9.78 391,000
2009-02-26 Bell Leonard (CEO) Option Ex 25,715 21.66 556,858
2009-02-17 Mathis Larry (Director) Sale 4,000 39.53 158,120
2009-02-17 Keiser David W (Director) Sale 55,515 39.46 2,190,621
2009-02-17 Keiser David W (Director) Option Ex 40,000 34.28 1,371,320
2009-01-16 Sinha Vikas (Sr. VP & CFO) Sale 1,661 36.84 61,191
2009-01-16 Squinto Stephen P (EVP & Head of Research) Sale 1,348 36.81 49,619
2009-01-16 Keiser David W (Director) Sale 2,110 36.90 77,859
2009-01-16 Bell Leonard (CEO) Sale 4,997 36.89 184,339
2009-01-16 Dubin Thomas I H (SVP & General Counsel) Sale 1,049 36.93 38,739
2009-01-12 Sinha Vikas (Sr. VP & CFO) Sale 375 34.48 12,929
2009-01-12 Squinto Stephen P (EVP & Head of Research) Sale 375 34.48 12,929
2009-01-12 Keiser David W (Director) Sale 375 34.51 12,941
2009-01-12 Bell Leonard (CEO) Sale 1,340 34.44 46,149
2009-01-12 Dubin Thomas I H (SVP & General Counsel) Sale 282 34.48 9,723
2008-10-29 Madri Joseph A (Director) Sale 4,000 38.23 152,920
2008-10-29 Madri Joseph A (Director) Option Ex 4,000 5.88 23,520
2008-09-22 Sinha Vikas (Sr. VP & CFO) Sale 2,065 41.37 85,429
2008-09-11 Squinto Stephen P (EVP & Head of Research) Sale 319 40.20 12,823
2008-09-11 Keiser David W (President & COO) Sale 638 40.24 25,672
2008-09-11 Dubin Thomas I H (SVP & General Counsel) Sale 1,031 40.12 41,363
2008-08-08 Dubin Thomas I H (SVP and General Counsel) Sale 9,442 90.47 854,216
2008-08-05 Parven Alvin S (Director) Sale 9,500 91.63 870,485
2008-08-05 Parven Alvin S (Director) Option Ex 9,500 82.38 782,562
2008-08-01 Sinha Vikas (Sr VP and CFO) Sale 10,000 92.88 928,800
2008-08-01 Sinha Vikas (Sr VP and CFO) Option Ex 10,000 27.58 275,800
2008-07-31 Waeger Ruedi E (Director) Sale 19,500 93.63 1,825,785
2008-07-31 Waeger Ruedi E (Director) Option Ex 19,500 20.14 392,632
2008-07-30 Keiser David W (President & COO) Sale 10,000 90.00 900,000
2008-07-30 Keiser David W (President & COO) Option Ex 10,000 21.00 210,000
2008-07-25 Keiser David W (President & COO) Sale 20,000 80.00 1,600,000
2008-07-25 Keiser David W (President & COO) Option Ex 20,000 19.94 398,840
2008-07-10 Sinha Vikas (SVP & CFO) Sale 159 75.75 12,044
2008-07-10 Squinto Stephen P (EVP & Head of Research & Devel) Sale 159 75.75 12,044
2008-07-10 Keiser David W (President & COO) Sale 159 75.75 12,044
2008-07-10 Dubin Thomas I H (SVP & General Counsel) Sale 120 75.75 9,090
2008-07-01 Keiser David W (President & COO) Sale 20,000 71.87 1,437,400
2008-07-01 Keiser David W (President & COO) Option Ex 20,000 17.15 342,920
2008-06-04 Parven Alvin S (Director) Sale 6,500 70.57 458,685
2008-06-04 Parven Alvin S (Director) Option Ex 6,500 21.76 141,440
2008-05-19 Squinto Stephen P (EVP & Head of Research & Devel) Sale 35,827 69.81 2,500,975
2008-05-19 Squinto Stephen P (EVP & Head of Research & Devel) Option Ex 35,827 17.87 640,156
2008-05-14 Mathis Larry (Director) Sale 2,000 71.02 142,030
2008-05-01 Keiser David W (President & COO) Sale 50,000 70.06 3,502,850
2008-04-23 Bell Leonard (CEO) Sale 8,590 70.00 601,300
2008-04-23 Bell Leonard (CEO) Option Ex 12,000 9.00 108,000
2008-03-24 Sinha Vikas (SVP & Chief Financial Officer) Sale 1,025 58.23 59,685
2008-03-10 Squinto Stephen P (EVP & Head of Research) Sale 159 56.05 8,911
2008-03-10 Keiser David W (President & COO) Sale 159 56.05 8,911
2008-03-10 Dubin Thomas I H (SVP & General Counsel) Sale 515 56.05 28,865
2008-02-22 Parven Alvin S (Director) Sale 2,000 61.35 122,700
2008-02-20 Norby R Douglas (Director) Sale 2,000 61.58 123,160
2008-02-12 Bell Leonard (CEO) Sale 8,590 70.01 601,385
2008-02-12 Bell Leonard (CEO) Option Ex 12,000 9.00 108,000
2008-01-10 Sinha Vikas (SVP & Chief Financial Officer) Sale 711 69.02 49,073
2008-01-10 Squinto Stephen P (EVP & Head of Research) Sale 712 69.02 49,142
2008-01-10 Keiser David W (President & COO) Sale 709 69.02 48,935
2008-01-10 Dubin Thomas I H (SVP & General Counsel) Sale 555 69.02 38,306
2007-12-17 Bell Leonard (CEO) Sale 8,090 73.99 598,587
2007-12-17 Bell Leonard (CEO) Option Ex 12,300 41.50 510,450
2007-12-13 Keiser David W (President & COO) Sale 12,500 75.03 937,937
2007-12-13 Keiser David W (President & COO) Option Ex 12,500 9.00 112,500
2007-11-29 Dubin Thomas I H (SVP & General Counsel) Sale 1,650 75.20 124,080
2007-11-28 Dubin Thomas I H (SVP & General Counsel) Sale 20,000 14.21 284,100
2007-11-28 Dubin Thomas I H (SVP & General Counsel) Option Ex 20,000 74.25 1,483,963
2007-11-15 Bell Leonard (CEO) Sale 8,400 73.34 616,047
2007-11-15 Bell Leonard (CEO) Option Ex 12,000 9.00 108,000
2007-11-05 Squinto Stephen P (EVP & Head of Research) Sale 34,998 75.03 2,625,899
2007-11-05 Squinto Stephen P (EVP & Head of Research) Option Ex 33,465 21.00 702,765
2007-11-01 Keiser David W (President & COO) Sale 12,500 76.32 953,999
2007-11-01 Keiser David W (President & COO) Option Ex 12,500 9.00 112,500
2007-10-29 Parven Alvin S (Director) Option Ex 22,000 78.92 1,736,350
2007-09-24 Sinha Vikas (SVP & Chief Financial Officer) Sale 4,162 63.40 263,883
2007-09-10 Squinto Stephen P (EVP & Head of Research) Sale 209 65.31 13,649
2007-09-10 Keiser David W (President & COO) Sale 209 65.22 13,632
2007-09-10 Dubin Thomas I H (SVP & General Counsel) Sale 514 65.31 33,569
2007-08-21 Madri Joseph A (Director) Sale 500 58.98 29,492
2007-08-21 Madri Joseph A (Director) Option Ex 2,000 10.38 20,760
2007-07-30 Keiser David W (President & COO) Sale 4,250 58.77 249,785
2007-07-30 Keiser David W (President & COO) Option Ex 4,250 10.50 44,625
2007-07-25 Squinto Stephen P (EVP & Head of Research) Sale 25,000 56.70 1,417,500
2007-07-25 Squinto Stephen P (EVP & Head of Research) Option Ex 25,000 9.99 249,874
2007-06-11 Link Max (Director) Option Ex 35,166 19.64 690,484
2007-06-01 Squinto Stephen P (EVP & Head of Research) Sale 25,000 48.50 1,212,500
2007-06-01 Squinto Stephen P (EVP & Head of Research) Option Ex 25,000 9.25 231,250
2007-05-29 Mojcik Christopher F (SVP Clinical Development) Buy 5,023 47.11 236,633
2007-05-29 Mojcik Christopher F (SVP Clinical Development) Sale 98,852 47.34 4,671,553
2007-05-29 Mojcik Christopher F (SVP Clinical Development) Option Ex 103,875 .00 0
2007-05-08 Keiser David W (President & COO) Sale 9,375 47.00 440,625
2007-05-08 Keiser David W (President & COO) Option Ex 9,375 10.50 98,437
2007-03-26 Bell Leonard (CEO) Sale 19,580 44.26 866,610
2007-03-26 Bell Leonard (CEO) Option Ex 30,000 10.38 311,400
2007-03-12 Squinto Stephen P (EVP & Head of Research) Sale 758 37.15 28,159
2007-03-12 Mojcik Christopher F (SVP Clinical Development) Sale 569 37.15 21,138
2007-03-12 Dubin Thomas I H (SVP & General Counsel) Sale 758 37.15 28,159
2007-01-03 Keiser David W (President & COO) Sale 9,375 40.58 380,465
2007-01-03 Keiser David W (President & COO) Option Ex 9,375 10.50 98,437
2006-11-22 Keiser David W (President & COO) Option Ex 2,000 10.50 21,000
2006-11-14 Bell Leonard (Chief Executive Officer) Sale 19,350 42.32 818,911
2006-11-14 Bell Leonard (Chief Executive Officer) Option Ex 30,000 10.38 311,400
2006-11-09 Bell Leonard (Chief Executive Officer) Sale 19,725 40.03 789,591
2006-11-09 Bell Leonard (Chief Executive Officer) Option Ex 30,000 10.38 311,400
2006-11-03 Parven Alvin S (Director) Option Ex 6,400 38.49 246,316
2006-10-16 Bell Leonard (Chief Executive Officer) Sale 20,100 37.86 760,986
2006-10-16 Bell Leonard (Chief Executive Officer) Option Ex 30,000 10.38 311,400
2006-09-15 Bell Leonard (Chief Executive Officer) Sale 21,200 33.90 718,722
2006-09-15 Bell Leonard (Chief Executive Officer) Option Ex 30,000 10.38 311,400
2006-08-10 Link Max (Director) Sale 16,580 31.60 523,928
2006-03-10 Keiser David W (President & COO) Sale 3,005 38.35 115,241
2006-03-10 Keiser David W (President & COO) Option Ex 3,005 10.00 30,050
2006-03-10 Bell Leonard (Chief Executive Officer) Sale 8,907 38.35 341,583
2006-03-10 Bell Leonard (Chief Executive Officer) Option Ex 8,907 10.00 89,070
2006-02-15 Squinto Stephen P (EVP & Head of Research) Sale 5,000 35.05 175,250
2006-02-15 Squinto Stephen P (EVP & Head of Research) Option Ex 5,000 10.50 52,500
2006-02-15 Bell Leonard (Chief Executive Officer) Sale 10,000 35.01 350,100
2006-02-15 Bell Leonard (Chief Executive Officer) Option Ex 10,000 10.00 100,000
2006-02-01 Keiser David W (President & COO) Sale 20,000 30.19 603,820
2006-02-01 Keiser David W (President & COO) Option Ex 20,000 10.00 200,000
2006-01-30 Bell Leonard (Chief Executive Officer) Sale 10,000 28.40 284,000
2006-01-30 Bell Leonard (Chief Executive Officer) Option Ex 10,000 10.00 100,000
2005-11-01 Link Max (Director) Buy 2,500 21.76 54,400
2005-10-13 Parven Alvin S (Director) Buy 1,049 26.74 28,050
2005-10-10 Mathis Larry (Director) Buy 1,000 26.25 26,255
2005-10-10 Link Max (Director) Buy 15,000 26.78 401,640
2005-10-07 Mathis Larry (Director) Buy 1,000 26.52 26,520
2005-06-27 Boess Carsten (Other) Sale 11,250 23.38 263,025
2005-06-15 Bowdish Katherine S (Senior Vice Presiden) Sale 0 21.57 0
2005-06-08 Rollins Scott A (Proj. Man.) Sale 1,900 22.25 42,275

Insider trading activities including stock purchases, stock sales, and option exercises of ALXN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alexion Pharmaceuticals Inc (symbol ALXN, CIK number 899866) see the Securities and Exchange Commission (SEC) website.